From the discovery of epinephrine to the development of the statin class of lipid-lowering agents; and the development of the first glitazone; which revolutionized long-term control of type 2 diabetes; the people of Daiichi Sankyo remain committed to a unique ideal. To physicians; this means objective data; the highest ethical standards; and a desire to deliver practical human benefits with each product we develop. To our partners; we balance the strength and stability of our global presence with the spirit; agility; and quick reaction times of much smaller companies. To our employees; we offer an operational structure that balances creativity with discipline and individualism with collaboration. To patients; we are committed to developing medications that put lives into balance. We believe good science walks hand-in-hand with humanityand; as we move forward into our next century; Daiichi Sankyo seeks to build on our history of discovery with the development of new therapies in cardiovascular disease; cancer; metabolic disorders; and infection.
Discover specific contacts and email addresses at Daiichi Sankyo, Inc..
Request a full profile of Daiichi Sankyo, Inc. with decision maker contacts and email address:
There are few of many reasons that companies of all sizes trust Ready to build databases for their campaigns.